Astera Labs, Inc. $ALAB Shares Sold by FengHe Fund Management Pte. Ltd.

FengHe Fund Management Pte. Ltd. reduced its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 72.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 324,000 shares of the company’s stock after selling 856,848 shares during the quarter. Astera Labs accounts for about 5.8% of FengHe Fund Management Pte. Ltd.’s holdings, making the stock its 4th biggest holding. FengHe Fund Management Pte. Ltd. owned approximately 0.19% of Astera Labs worth $63,439,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Royal Bank of Canada lifted its holdings in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after acquiring an additional 95,409 shares during the last quarter. AQR Capital Management LLC increased its position in Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Astera Labs by 15,180.1% in the 1st quarter. Jones Financial Companies Lllp now owns 20,781 shares of the company’s stock valued at $1,240,000 after purchasing an additional 20,645 shares during the last quarter. Empowered Funds LLC boosted its position in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares in the last quarter. Finally, Focus Partners Wealth boosted its position in Astera Labs by 0.8% in the first quarter. Focus Partners Wealth now owns 432,806 shares of the company’s stock valued at $25,826,000 after buying an additional 3,464 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other Astera Labs news, CFO Michael Truett Tate sold 11,430 shares of the company’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the sale, the chief financial officer owned 192,297 shares of the company’s stock, valued at approximately $27,823,452.93. This represents a 5.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Sanjay Gajendra sold 90,459 shares of the stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at approximately $231,467,827.50. The trade was a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 576,936 shares of company stock worth $87,409,540. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 3.8%

Shares of ALAB stock opened at $162.61 on Friday. The stock has a market cap of $27.46 billion, a price-to-earnings ratio of 146.50, a PEG ratio of 2.14 and a beta of 1.50. The stock has a 50-day moving average of $159.79 and a 200-day moving average of $162.80. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm’s quarterly revenue was up 103.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on ALAB shares. Cowen reiterated a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, October 8th. Wall Street Zen downgraded Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Northland Securities boosted their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Finally, Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $188.17.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.